Anti-miRNA-based therapeutics for human cancer: The E2F-1-c-Myc-miRNA-17-92 pathway suppresses widespread miRNA biogenesis via down regulation of its target gene, 16/May/2014, 9.00 am

Molecular cancer therapy: Tumor suppressor BMP4 suppresses the expression of SRSF1 via up regulation of its target gene, 16/May/2014, 8.20 am
May 16, 2014
The reprogramming protein Oct4 suppresses the expression of eIF5A2 via up regulation of its target gene, 16/May/2014, 7.38 am
May 16, 2014
Show all

Profs. Drs. R I Gregory, Camargo FD and their co-workers from Boston Children’s Hospital, MA, USA; Department of Biological Chemistry and Molecular Pharmacology and Department of Pediatrics, Harvard Medical School, Boston, MA, USA; and Harvard Stem Cell InstituteBoston, MA, USA had reported in the prestigious journal Cell (Feb 27, 2014) that Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer”  

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Anti-miRNA-based therapeutics for human cancer: The E2F-1-c-Myc-miRNA-17-92 pathway suppresses widespread miRNA biogenesis via down regulation of its target gene. This data may suggest that miRNA-17-92  cluster functions as an oncomiR by suppressing the network of tumor suppressor miRNAs.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L, Anti-miRNA-based therapeutics for human cancer: The E2F-1-c-Myc-miRNA-17-92 pathway suppresses widespread miRNA biogenesis via down regulation of its target gene, 16/May/2014, 9.00 am

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.